ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2000, p. 2777–2783 0066-4804/00/$04.00⫹0 Copyright © 2000, American Society for Microbiology. All Rights Reserved.
Vol. 44, No. 10
Animal and Human Multidrug-Resistant, Cephalosporin-Resistant Salmonella Isolates Expressing a Plasmid-Mediated CMY-2 AmpC -Lactamase P. L. WINOKUR,1,2* A. BRUEGGEMANN,1 D. L. DESALVO,2 L. HOFFMANN,3 M. D. APLEY,3 E. K. UHLENHOPP,3 M. A. PFALLER,1 AND G. V. DOERN1 University of Iowa College of Medicine1 and The Veterans Affairs Medical Center,2 Iowa City, and Iowa State College of Veterinary Medicine, Ames,3 Iowa Received 18 February 2000/Returned for modification 21 June 2000/Accepted 25 July 2000
Salmonella spp. are important food-borne pathogens that are demonstrating increasing antimicrobial resistance rates in isolates obtained from food animals and humans. In this study, 10 multidrug-resistant, cephalosporin-resistant Salmonella isolates from bovine, porcine, and human sources from a single geographic region were identified. All isolates demonstrated resistance to cephamycins and extended-spectrum cephalosporins as well as tetracycline, chloramphenicol, streptomycin, and sulfisoxazole. Molecular epidemiological analyses revealed eight distinct chromosomal DNA patterns, suggesting that clonal spread could not entirely explain the distribution of this antimicrobial resistance phenotype. However, all isolates encoded an AmpC-like -lactamase, CMY-2. Eight isolates contained a large nonconjugative plasmid that could transform Escherichia coli. Transformants coexpressed cephalosporin, tetracycline, chloramphenicol, streptomycin, and sulfisoxazole resistances. Plasmid DNA revealed highly related restriction fragments though plasmids appeared to have undergone some evolution over time. Multidrug-resistant, cephalosporin-resistant Salmonella spp. present significant therapeutic problems in animal and human health care and raise further questions about the association between antimicrobial resistance, antibiotic use in animals, and transfer of multidrug-resistant Salmonella spp. between animals and man. sistant Salmonella isolates that are resistant to extended-spectrum cephalosporins and cephamycins. A plasmid-mediated CMY-2 ampC-like gene was identified in all animal and human isolates. Plasmid-mediated AmpC-type -lactamases have been identified in Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, and Enterobacter aerogenes clinical isolates from humans in the United States, Europe, and other regions (5, 9, 44). Reports of human Salmonella isolates expressing an AmpClike -lactamase have been quite rare (15, 23), though the prevalence may be increasing (E. F. Dunne, P. F. Fey, P. Shillam, P. Kludt, W. Keene, E. Harvey, K. Stamey, T. Barrett, N. Marano, and F. J. Angulo, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 716, 1999). Additionally, animal Salmonella isolates expressing an AmpC-like enzyme have not been reported. In this study, the molecular characterization of cephalosporin-resistant Salmonella isolates from food animals and humans residing in a single geographic region is reported. These results underscore concern for increasing antimicrobial resistance in Salmonella spp. and suggest that careful epidemiological and antimicrobial surveillance studies are needed to assess the selective conditions associated with cephalosporin resistance among Salmonella isolates from farm animals and the association of these isolates with human disease.
Salmonella spp. are important zoonotic pathogens in humans and animals. In the United States it is estimated that over 1.4 million cases of salmonellosis occur each year, 95% of which are the result of food-borne transmission (28). Large outbreaks have been associated with ingestion of poultry, meat, and milk and other dairy products (6). Although the majority of infections result in asymptomatic or self-limited diarrheal illness, severe, life-threatening bacteremias and other deep-seated infections do occur, particularly in immunocompromised hosts, neonates, and the elderly (7, 14). Increasing rates of antimicrobial resistance in Salmonella isolates have been reported from a number of developing and developed countries. In the United States, resistance to tetracycline increased from 9% in 1980 to 24% in 1990 and resistance to ampicillin increased from 10 to 14% (25). In Britain, rates of antimicrobial resistance for Salmonella enterica serovar Typhimurium were higher, with 45% of isolates resistant to tetracyclines, 40% of isolates resistant to sulfonamides, and 17% of isolates resistant to ampicillin (42). Much of this multidrug resistance has been linked to the spread of a single strain of Salmonella serovar Typhimurium, definitive phage type 104 (DT104), through food animals and humans (16). Most of these multidrug-resistant DT104 isolates have a chromosomal gene cluster that codes for resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (11, 37). Of increasing concern is the fact that animal- and humanassociated multidrug-resistant DT104 isolates resistant to quinolones have been reported (29, 41). In this study, we report the identification and molecular characterization of bovine, porcine, and human multidrug-re-
MATERIALS AND METHODS Organisms. A total of 158 isolates of Salmonella spp. were recovered from various animals between November 1998 and May 1999 at the Iowa State University Veterinary Diagnostic Microbiology Laboratory. Organisms were obtained from liver, stool, intestine, lung, and lymph node samples of diseased animals. A total of 320 human isolates of Salmonella spp. were analyzed. These isolates had been referred to the Iowa State Hygienic Laboratory from numerous microbiology laboratories throughout the state of Iowa. All isolates were transferred to the Medical Microbiology Division of the Department of Pathology at the University of Iowa College of Medicine for further characterization. Isolates were stored at ⫺70°C on porous beads (ProLab, Austin, Tex.) until further use.
* Corresponding author. Mailing address: SW34 GH, 200 Hawkins Dr., Iowa City, IA 52242. Phone: (319) 356-3909. Fax: (319) 345-4600. E-mail:
[email protected]. 2777
2778
WINOKUR ET AL.
ANTIMICROB. AGENTS CHEMOTHER. TABLE 1. Cephalosporin-resistant Salmonella isolates
Antibiotic resistancesa
PFGE type
pIc
None
F
5.4, 8.7
Typhimurium
U302
Elkader
Unknown
A
5.4, 8.7
NT
Intestine
Webster City
None
C
5.4, 8.7
Typhimurium subsp. copenhagen Heidelberg
Porcine Porcine Porcine
Liver Intestine Intestine
Hospers Lorimar Beaman
Unknown Unknown Ceftiofur, florfenicol
B B D
5.4, 8.7 5.4, 8.7 8.7
Typhimurium Typhimurium Give
DT6 DT6
530 532
Bovine Bovine
Lymph node Intestine
Atlantic Strawberry Point
None Amprolium
E A
8.7 5.4, 8.7
R1339 R1849
Human Human
Stool Stool
Iowa City Mason City
Unknown Unknown
X Y
8.7 8.7
Heidelberg Typhimurium subsp. copenhagen Typhimurium Newport
Source
Cityb
Isolate
Species
CeSSuCTGTsF
613
Bovine
Lung
Corydon
CeSSuCTGTs
263
Bovine
Fecal
370
Porcine
CeSSuCTG
272 274 447
CeSSuCT
Antibiotic use
Serovar
Phage typea
NT DT104
a Resistances are shown by different combinations of the following abbreviations: Ce, cephalosporins; S, streptomycin; Su, sulfamethoxazole; C, chloramphenicol; T, tetracycline; G, gentamicin; Ts, trimethoprim-sulfamethoxazole; and F, flouroquinolone. b All cities listed are in Iowa. c pI determined by isoelectric focus analysis. d Phage typing performed on Salmonella serovar Typhimurium and serovar Typhimurium subsp. copenhagen isolates. NT, nontypeable.
Antimicrobial susceptibility testing. MICs of selected antimicrobials were determined by broth microdilution as described by the National Committee for Clinical Laboratory Standards. Custom-designed, cation-adjusted Mueller-Hinton broth microdilution trays purchased from TREK Diagnostic Systems Inc., Westlake, Ohio, were inoculated and incubated at 35°C for 16 to 20 h (21, 31). Sulfadiazine and sulfisoxazole susceptibility tests were performed by disk diffusion (21, 31). Cefoxitin and streptomycin MICs were determined using the E test methodology as described by the manufacturer (AB Biodisk, Solna, Sweden). Briefly, organisms were diluted to a McFarland standard of 0.5 and streaked onto Mueller-Hinton agar plates. After E-test strip application, the plates were incubated at 35°C for 16 to 20 h. Isoelectric focus analysis. Crude -lactamase extracts were prepared by freeze-thaw lysis of bacterial cultures grown to exponential-growth stage in tryptic soy broth as previously described (8). Analytical isoelectric focusing was performed using a Multiphore II electrophoresis system with commercially prepared ampholine-polyacrylamide plates (pI 3.5 to 9.5; Amersham Pharmacia Biotech, Piscataway, N.J.). -lactamase activity was detected with 0.5 mg of nitrocephin (Becton-Dickinson, Franklin Lakes, N.J.) per ml. TEM-1, TEM-4, SHV-1, SHV-3, and SHV-5 -lactamases expressed in E. coli C600 were used as isoelectric focus standards. These enzymes are known to migrate at pIs of 5.4, 5.9, 7.6, 7.0, and 8.2, respectively (22). Known pIs of each standard were plotted against the distance from the cathode, and a regression analysis was performed (using Microsoft Excel 98 software). Unknown -lactamase pIs were calculated using the regression curve generated from each gel. Pulsed-field gel electrophoresis. Genomic DNA was isolated and digested with XbaI (New England Biolabs, Beverly, Mass.) as previously described (32). Electrophoresis was performed on the CHEF-DRII (Bio-Rad Laboratories, Richmond, Calif.) with the following conditions: 0.5⫻ Tris-borate-EDTA, 1% agarose, 13°C, 6 V/cm for 23 h (with switch times ranging from 5 to 60 s). Molecular weight standards were a ladder that contained concatamers of the 48.5-kb phage DNA (FMC BioProduct, Rockland, Maine). Gels were stained with ethidium bromide and photographed using a Gel Doc 1000 system (Bio-Rad Laboratories). Strains which contained restriction fragment patterns that differed by more than three bands were considered unique (2). Molecular techniques. Plasmid DNA was isolated using the Concert MiniPrep system (Gibco BRL). Alternatively, large plasmids were isolated using a protocol described previously for isolation of large bacterial artificial chromosome plasmid DNA (36). Large plasmid DNA was then digested using PlasmidSafe DNase (Epicentre Technologies, Madison, Wis.) according to the manufacturer’s recommendations. Conjugation experiments were performed as previously described (35). Briefly, cultures of the E. coli recipient HB101 containing pEm7/Zeo (a Zeocin resistance plasmid; Invitrogen, Carlsbad, Calif.) and the donor Salmonella isolate were grown overnight in Luria broth (LB). A 10:1 suspension of donor-recipient culture was diluted in fresh LB. Aliquots were spotted onto sterile filters placed on LB plates and incubated overnight. Filters were eluted in sterile saline, and serial dilutions were plated on LB plus Zeocin (50 g/ml) and cefoxitin (50 g/ml). Transformation of large plasmid DNA from the Salmonella isolates was performed using standard electroporation techniques with DH10B electrocompetent E. coli (Gibco BRL, Grand Island, N.Y.). Transformants were selected on LB agar containing 50 g of cefoxitin (Sigma, St.
Louis Mo.) per ml. Plasmid DNA restriction fragment length polymorphisms were analyzed by agarose gel electrophoresis of plasmid DNA cleaved with various restriction endonucleases (New England Biolabs). PCR analysis was performed on total DNA as prepared using the CTAB protocol described previously (4) or plasmid DNA treated with PlasmidSafe DNase. Amplification was performed with consensus primers for the bla genes encoding BIL-1, LAT-1, LAT-2, and CMY-2 and the ampC gene of Citrobacter freundii OS60 (ampC1, 5⬘-ATGATGAAAAAATCGTTATGC-3⬘; ampC2, 5⬘-T TGCAGCTTTTCAAGAATGCGC-3⬘ [23]) or TEM-1 (5⬘-CCCGAATTCGGA AGAGTATGAGTATTC-3⬘ and 5⬘-CCCGGATCCCAGTTACCAATGCTTA ATC-3⬘). PCR fragments were isolated using Qiaquick PCR cleanup columns (Qiagen, Valencia, Calif.). DNA sequence analysis was performed using Big Dye terminator cycle sequencing chemistry with AmpliTaq polymerase FS enzyme (Applied Biosystems, Foster City, Calif.). The reactions were performed and analyzed with an Applied Biosystems model 373A stretch fluorescent automated sequencer at the University of Iowa DNA Core Facility.
RESULTS Characterization of animal and human Salmonella isolates. Eight of 158 (5.1%) Salmonella isolates recovered from symptomatic large animals were determined to be resistant to extended-spectrum cephalosporins (ceftazidime, cefotaxime, and ceftiofur), a monobactam (aztreonam), and a cephamycin (cefoxitin), as well as to ticarcillin and piperacillin (Tables 1 and 2). The -lactamase inhibitor clavulanic acid (fixed concentration of 2 g/ml) had no effect on ticarcillin or ampicillin MICs (data not shown). As seen in other CMY studies, tazobactam reduced piperacillin MICs by fourfold or more in most isolates, though in this study the majority of isolates remained resistant to this antimicrobial combination (23, 44). All eight isolates were resistant to tetracycline, sulfamethoxazole, streptomycin, and chloramphenicol. In addition, six of eight isolates were resistant to gentamicin and three of eight isolates were resistant to trimethoprim-sulfamethoxazole. One isolate (isolate 613) was intermediate to ciprofloxacin and resistant to nalidixic acid. All eight isolates had been obtained from bovine or porcine sources in geographically distinct areas of Iowa. The majority of isolates were obtained from deep-seated sites, including lung, intestine, and liver or lymph node, with one isolate recovered from stool. Organisms represented a variety of serotypes though five isolates were Salmonella serovar Typhimurium
ANIMAL AND HUMAN DRUG-RESISTANT SALMONELLA ISOLATES
VOL. 44, 2000
2779
TABLE 2. Antimicrobial susceptibilities Isolate or transformanta
613 DH10B 263 DH10B 370 272 DH10B 274 447 DH10B 530 DH10B 532 DH10B R1339 DH10B R1849 DH10B DH10B
613 263 272 447 530 532 R1339 R1849
Result of testb: Amp
Pip
Pip-tazo
CTAZ
CTX
CFTI
CFOXc
CPIM
Tet
T/S
Gent
Strepc
Chlor
Cipro
Sulf
⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 4
⬎128 ⬎128 ⬎128 ⬎128 ⬎128 ⬎128 64 ⬎128 128 64 128 128 ⬎128 128 ⬎128 64 128 ⬎128 4
⬎64 32 ⬎64 8 64 64 16 32 16 8 64 32 ⬎64 64 64 32 32 ⬎64 2
⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 0.5
⬎32 16 ⬎32 16 ⬎32 ⬎32 32 32 ⬎32 16 32 32 32 ⬎32 ⬎32 ⬎32 32 ⬎32 ⱕ0.25
⬎32 NT ⬎32 NT ⬎32 ⬎32 NT NT 32 NT 32 NT ⬎32 NT 32 NT ⬎32 NT NT
⬎256 ⬎256 ⬎256 ⬎256 128 128 256 ⬎256 256 128 128 ⬎256 ⬎256 ⬎256 128 ⬎256 128 ⬎256 8
4 0.5 1 0.5 0.5 1 1 0.5 0.5 0.25 0.5 1 1 4 0.5 1 0.5 2 ⱕ0.12
⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⬎8 ⱕ4
⬎1 ⱕ0.5 ⬎1 ⬎1 ⬎1 ⱕ0.5 ⱕ0.5 ⱕ0.5 ⱕ0.5 1 ⱕ0.5 0.5 ⱕ0.5 1 0.5 1 0.5 0.5 ⱕ0.5
⬎16 0.5 16 16 ⬎16 ⬎16 ⬎16 ⬎16 8 0.5 1 0.5 0.5 0.5 0.5 0.5 0.25 0.25 0.5
⬎256 ⬎256 ⬎256 ⬎256 256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 ⬎256 256
⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 ⬎16 4
2 ⱕ0.015 0.06 ⱕ0.015 0.03 0.03 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015 0.03 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015 ⱕ0.015
6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 22
a
E. coli transformants are indicated by designations beginning DH10B. Amp, ampicillin; Pip; piperacillin, Pip-tazo, piperacillin combined with a fixed concentration of tazobactam (4 g/ml); CTAZ, ceftazidime; CTX, ceftriaxone; CFTI, ceftiofur; CFOX, cefoxitin; CPIM, cefepime; Tet, tetracycline; T/S, trimethoprim/sulfamethoxazole; Gent, gentamycin; Strep, streptomycin; Chlor, chloramphenicol; Sulf, sulfisoxazole; Cipro, ciprofloxacin. Values are MICs (in micrograms per milliliter), except that sulfisoxazole disk results are zone diameters (in nanometers). c Antimicrobial susceptibility determined by E-test methodology. d NT, not tested. b
or Salmonella serovar Typhimurium subsp. copenhagen. None of these isolates were DT104. Two of 320 (0.6%) human isolates of Salmonella spp. submitted to the Iowa State Hygienic Laboratory during 1998 were found to have antibiograms similar to the animal isolates. Both had been recovered from stool specimens in two geographically distinct cities in Iowa. The serotypes were Salmonella serovar Typhimurium and Salmonella serovar Newport. The Salmonella serovar Typhimurium isolate, 1339, was DT104. Both human isolates were resistant to cephalosporins as well as tetracycline, streptomycin, chloramphenicol, and sulfamethoxazole. Molecular epidemiology. The clonal relatedness of the 10 multidrug-resistant isolates of Salmonella was assessed by pulsed-field gel electrophoresis (PFGE) analysis of restriction endonuclease-digested chromosomal DNA (Fig. 1 and Table 1). Overall, eight distinct PFGE patterns were identified in the 10 organisms. Two bovine isolates demonstrated identical chromosomal DNA patterns, and two porcine isolates shared a different restriction fragment pattern. There was no obvious geographic link between isolates demonstrating similar PFGE patterns. Additionally, the PFGE patterns of the human isolates differed from those of the animal isolates. Molecular analysis of cephalosporin resistance. The antibiogram demonstrated by these organisms was consistent with the expression of a cephalosporinase similar to the chromosomally encoded inducible AmpC enzymes found in many members of Enterobacteriaceae. However, Salmonella species are not known to encode an inducible chromosomal AmpC enzyme (27). To determine whether these organisms expressed a -lactamase, crude bacterial isolates were analyzed by isoelectric gel electrophoresis. A -lactamase with a pI of ⱖ8.7 was detected in all 10 isolates. Additionally, five isolates demonstrated a second -lactamase that comigrated with the TEM-1 control, with a pI of 5.4. Conjugation studies were performed to determine whether cephalosporin resistance could be transferred to E. coli. De-
spite multiple attempts, resistance could not be transferred by conjugation to a recipient E. coli strain carrying a Zeocin resistance plasmid (HB101pE7zeo). Cephalosporin resistance, however, could be transferred through bacterial transformation. DH10B electrocompetent bacteria were transformed with Salmonella plasmid DNA. Eight of 10 Salmonella isolates
FIG. 1. PFGE of XbaI-digested chromosomal DNA of Salmonella isolates. Isolates 912993, 12386, and 16033 are previously characterized Salmonella serovar Typhimurium DT104 isolates (13). MWM, molecular weight standard (a DNA ladder containing concatamers of the 48.5-kb phage DNA).
2780
WINOKUR ET AL.
ANTIMICROB. AGENTS CHEMOTHER.
FIG. 2. PstI- or EcoRI-digested plasmid DNA isolated from the DH10B E. coli transformants.
transferred cephalosporin resistance. Additionally, resistances to tetracycline, sulfamethoxazole, and chloramphenicol were transferred to E. coli. Since DH10B E. coli is streptomycin resistant, this experiment was unable to determine whether streptomycin resistance was also present on plasmid DNA. Transfer of gentamicin resistance was less consistent. Only two of four Salmonella isolates carrying gentamicin resistance transferred this resistance to E. coli. Trimethoprim-sulfamethoxazole resistance cosegregated in one of two isolates while quinolone resistance did not cotransfer from the one isolate that expressed this resistance. All transformants expressed plasmid DNA that migrated at approximately 75 kb on agarose gels. Additionally, all transformants demonstrated -lactamase with a pI of ⱖ8.7. Two of three Salmonella isolates that originally expressed a -lactamase with a pI of 5.4 were able to transfer expression of this enzyme to E. coli (data not shown). The sequences, hydrolysis patterns, and isoelectric points of a number of -lactamases have been identified over the past decade (12). Review of the literature revealed a chromosomal AmpC enzyme identified in C. freundii that migrated at a pI of approximately 8.6 to 8.7 in isoelectric focus analysis (26, 39). Additionally, a single Salmonella serovar Seftenberg clinical isolate has been reported to carry a plasmid-mediated cephalosporinase that showed significant homology to the C. freundii ampC gene (23). PCR analysis of total bacterial DNA was performed using consensus primers for the Citrobacter family of ampC genes (23). A 1,143-bp fragment was amplified from all 10 Salmonella isolates while an unrelated Enterobacter cloacae isolate known to express a different AmpC enzyme and a
wild-type Salmonella isolate remained negative (data not shown). Each PCR fragment was isolated and the entire nucleotide sequence of the ampC-like gene was determined from both strands. All animal and human isolates contained an identical DNA sequence that has been designated CMY-2, an enzyme identified in a K. pneumoniae isolate found in Greece (5). A highly related though distinct enzyme, which differs only by two amino acids in the signal peptide sequence, has been identified in a single Salmonella serovar Seftenberg organism isolated from an Algerian child (23). TEM-1 PCR primers amplified the TEM gene from isolates 263, 272, 274, 370, 532, and 613, all of which expressed a -lactamase with a pI of 5.4. Plasmid restriction fragment length polymorphisms. Plasmid DNA from the E. coli transformants was isolated and digested with PstI, EcoRI (Fig. 2) or BamHI (data not shown). Complete identity between any plasmids was not observed. However, many fragments were shared among the transformants, suggesting that the plasmids may share a highly related plasmid backbone. DISCUSSION Antibiotic resistance in Salmonella has intensified substantially worldwide (19, 25, 33, 42, 46, 47). For years, ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol were the recommended antimicrobial agents for severe Salmonella infections. Rising rates of resistance to these agents have significantly reduced the efficacy of these agents. Consequently,
VOL. 44, 2000
ANIMAL AND HUMAN DRUG-RESISTANT SALMONELLA ISOLATES
fluoroquinolones and expanded-spectrum cephalosporins have become the recommended antimicrobial agents for invasive Salmonella infections. Multidrug-resistant, quinolone-resistant Salmonella strains are now being reported (29). The present study describes multidrug-resistant, cephalosporin-resistant Salmonella isolates from both food animals and humans. Salmonella isolates resistant to broad-spectrum cephalosporins were first reported in the 1980s, and since that time additional isolates have been identified (10, 30). The majority of cephalosporin-resistant Salmonella isolates express an extended-spectrum -lactamase able to hydrolyze oxyimino cephalosporins and monobactams but not the cephamycins. Recently, a second mechanism of cephalosporin resistance in Salmonella has been observed (4, 23). These isolates express plasmidmediated AmpC-like -lactamases that hydrolyze the cephamycins as well as the extended-spectrum cephalosporins and monobactams. The isolates described in the present study express a plasmid-mediated CMY-2 AmpC-like enzyme that has been identified previously in a single Salmonella isolate from Algeria (23). This enzyme belongs to a small family of plasmidmediated AmpC-like enzymes (LAT-1, LAT-2, BIL-1, CMY-2 and -2b, CMY-3, CMY-4, and CMY-5) that share homology with the chromosomal ampC from C. freundii (5, 23, 44, 45). Further analysis has shown that the plasmid-encoded CMY-5 gene is followed by the blc and sugE genes of C. freundii and this genetic organization is identical to that found on the C. freundii chromosome, providing strong evidence that the CMY genes have been translocated from Citrobacter to other bacterial species (45). AmpC-mediated cephalosporin-resistance in Salmonella appears to be more widespread in the United States than previously thought. The prevalence of cefoxitin and cefotaxime resistance in human isolates from this study was 0.6%, which is quite similar to recent (1998) data from the CDC National Antimicrobial Resistance Monitoring System, where 0.7% of over 1,400 U.S. isolates were resistant to ceftriaxone (Dunne et al., 39th ICAAC). The majority of the CDC isolates expressed a CMY-2-, LAT-1-, BIL-1-like enzyme (Dunne et al., 39th ICAAC). There are four additional isolates reported from the United States, though three of the four may have been acquired outside the United States (18, 20). Salmonella is widespread in nature and can colonize or infect a variety of domesticated and wild animals ranging from mammals to birds and reptiles. Most human nontyphoidal Salmonella infections in the United States are related to ingestion of contaminated food products rather than person-to-person transmission or direct fecal-oral transmission. Many outbreaks have been traced to ingestion of contaminated animal products, in some cases, derived from specific farms, flocks, or herds of animals (1, 29, 38). A recent outbreak in Denmark of quinolone-resistant Salmonella serovar Typhimurium DT104 infections was traced to contaminated pork products (29). Additional investigation identified two infected swine herds responsible for the outbreak (29). Sporadic cases have also been associated with consumption of animal products such as raw eggs and unpasteurized milk (17). The extended-spectrum cephalosporin ceftiofur has been approved for therapeutic veterinary use in the United States. This agent is used commonly for respiratory tract infections, metritis, foot rot, and abscess prophylaxis in day-old chicks. However, very little is known regarding the frequency of use of this agent. Nearly 6% of the veterinary Salmonella isolates examined in this study were resistant to extended-spectrum cephalosporins. This percentage does not reflect the overall carriage rate in asymptomatic animals or symptomatic animals that may have responded to empiric therapy, since all isolates
2781
were obtained from symptomatic animals. Nonetheless, the prevalence of resistance is striking. Also noteworthy is the fact that all isolates demonstrated resistance to streptomycin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline. Though Salmonella serovar Typhimurium, DT104 is the most common multidrug-resistant serotype, with 32% of recent isolates carrying the ampicillin-chloramphenicol-streptomycinsulfamethoxazole-tetracycline resistance phenotype, other serotypes express a similar resistance phenotype (1998 annual report of the National Antimicrobial Resistance Monitoring System, Centers for Disease Control and Prevention [http:// www.cdc.gov/ncidod/dbmd/narms/98toc.htm]). Antibiotic resistance can be spread throughout populations by epidemic spread of a particular isolate or through exchange of genetic material. In the present study, two pairs of isolates expressed identical or highly related PFGE patterns, possibly revealing a clonal relationship between some of the isolates. However, the fact that eight different PFGE patterns were identified suggests that the distribution of these isolates was not entirely due to clonal spread. Despite the fact that human salmonellosis is strongly linked to food from animal sources, there was no clonal relationship between the two human and eight animal isolates. A nonconjugative but transferable plasmid encoding the CMY-2 gene was identified in 80% of isolates in this study. All E. coli transformants demonstrated a plasmid of approximately 75 kb. Though the plasmids were not identical, in that cotransfer of gentamicin or trimethoprim-sulfamethoxazole occurred in only a subset of isolates and RFLP patterns were different, the cotransfer of CMY-2, chloramphenicol, sulfamethoxazole, tetracycline, and possibly streptomycin in all isolates suggests that a highly related gene cluster may reside on each plasmid from the human and animal isolates. Additionally, the RFLP patterns identified many highly conserved restriction fragments among each of the plasmids, suggesting that the plasmids may be genetically similar but that they may have evolved over time. Previous studies have shown that plasmid DNA can change rapidly (24, 40). DT104 isolates of Salmonella typically carry a chromosomal integron that encodes all or a subset of the antimicrobial resistance genes (11, 37). More recently, multidrug-resistant Salmonella serovar Typhimurium isolates that contain a similar integron-associated gene cluster encoded on a transferable plasmid have been identified (43). Transformants in this study were analyzed for type 1 integrons (34). All animal transformants demonstrated one or more integrons though preliminary evidence did not find the CMY-2 gene to be encoded within an integron (P. L. Winokur, unpublished data). It is tempting to speculate that acquisition of cephalosporin resistance may relate to therapeutic ceftiofur use. However, persistence of these multidrug-resistant strains of Salmonella spp. in farm animals may be further encouraged by the use of other antimicrobials as growth promotants, a common practice in the veterinary industry. The results of this study do not definitively prove spread of multidrug-resistant Salmonella from an animal source to humans. However, the genetic relatedness of the plasmids identified and their prevalence in the animal isolates is suggestive. Additional studies will be required to further explore the association of resistance with various antibiotic use practices in food animals carrying a cephalosporin-resistant Salmonella and the possible transfer of multidrug-resistant, cephalosporinresistant Salmonella spp. between animals and humans.
2782
WINOKUR ET AL. ACKNOWLEDGMENTS
We thank M. Loeffeholz at the Iowa State Hygienics Laboratory for providing human Salmonella isolates; B. D. Jones, University of Iowa, for providing the Salmonella serovar Typhimurium DT104 isolates; and M. Cormican and C. O’Hare, University of Ireland, Galway, United Kingdom, for phage type analysis. P.L.W. was supported in part by a VA Merit Review award.
ADDENDUM In a recent study, Fey et al. (14a) identified two multidrugresistant, cephalosporin-resistant Salmonella isolates that each carry a 160-kb plasmid encoding the CMY-2 gene. These isolates, one human and one bovine, were epidemiologically linked and shared similar PFGE patterns. These data suggest that ceftriaxone-resistant Salmonella has been transmitted from food animals to humans. REFERENCES 1. Altekruse, S., J. Koehler, F. Hickman-Brenner, R. V. Tauxe, and K. Ferris. 1993. A comparison of Salmonella enteritidis phage types from egg-associated outbreaks and implicated laying flocks. Epidemiol. Infect. 110:17–22. 2. Arbeit, R. D. 1995. Laboratory procedures for the epidemiologic analysis of microorganisms, p. 190–208. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology. American Society for Microbiology, Washington, D.C. 3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stzuhl. 1993. Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y. 4. Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible -lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352–2358. 5. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Giamarellou. 1996. Characterization of the plasmidic -lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221–224. 6. Bean, N. H., J. S. Goulding, C. Lao, and F. J. Angulo. 1996. Surveillance for foodborne-disease outbreaks—United States, 1988–1992. CDC Surveillance Summaries. Morbid. Mortal. Weekly Rep. 45:1–65. 7. Blaser, M. J., and R. A. Feldman. 1981. From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968– 1979. J. Infect. Dis. 143:743–746. 8. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing -lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761–766. 9. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC -lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563– 569. 10. Bradford, P. A., Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch. 1998. CTX-M-5, a novel cefotaxime-hydrolyzing -lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980–1984. 11. Briggs, C. E., and P. M. Fratamico. 1999. Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104. Antimicrob. Agents Chemother. 43:846–849. 12. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for -lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211–1233. 13. Carlson, S. A., L. F. Bolton, C. E. Briggs, H. S. Hurd, V. K. Sharma, P. J. Fedorka-Cray, and B. D. Jones. 1999. Detection of multiresistant Salmonella typhimurium DT104 using multiplex and fluorogenic PCR. Mol. Cell. Probes 13:213–222. 14. Celum, C. L., R. E. Chaisson, G. W. Rutherford, J. L. Barnhart, and D. F. Echenberg. 1987. Incidence of salmonellosis in patients with AIDS. J. Infect. Dis. 156:998–1002. 14a.Fey, P. D., et al. 2000. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342:1242–1249. 15. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable -lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85–87. 16. Glynn, M. K., C. Bopp, W. Dewitt, P. Dabney, M. Mokhtar, and F. J. Angulo. 1998. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. N. Engl. J. Med. 338:1333– 1338.
ANTIMICROB. AGENTS CHEMOTHER. 17. Hedberg, C. W., M. J. David, K. E. White, K. L. MacDonald, and M. T. Osterholm. 1993. Role of egg consumption in sporadic Salmonella enteritidis and Salmonella typhimurium infections in Minnesota. J. Infect. Dis. 167:107–111. 18. Herikstad, H., P. S. Hayes, J. Hogan, P. Floyd, L. Snyder, and F. J. Angulo. 1997. Ceftriaxone-resistant Salmonella in the United States. Pediatr. Infect. Dis. J. 16:904–905. 19. Hoge, C. W., J. M. Gambel, A. Srijan, C. Pitarangsi, and P. Echeverria. 1998. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 26:341–345. 20. Horton, J. M., R. F. Sing, and S. G. Jenkins. 1999. Multidrug-resistant Salmonella associated with AmpC hyperproduction. Clin. Infect. Dis. 29: 1348. 21. Isenberg, H. D. 1992. Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C. 22. Jacoby, G. A., and I. Carreras. 1990. Activities of -lactam antibiotics against Escherichia coli strains producing extended-spectrum -lactamases. Antimicrob. Agents Chemother. 34:858–862. 23. Koeck, J. L., G. Arlet, A. Philippon, S. Basmaciogullari, H. V. Thien, Y. Buisson, and J. D. Cavallo. 1997. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152:255–260. 24. Kron, M. A., D. M. Shlaes, C. Currie-McCumber, and A. A. Medeiros. 1987. Molecular epidemiology of OHIO-1 beta-lactamase. Antimicrob. Agents Chemother. 31:2007–2009. 25. Lee, L. A., N. D. Puhr, E. K. Maloney, N. H. Bean, and R. V. Tauxe. 1994. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989–1990. J. Infect. Dis. 170:128–134. 26. Lindberg, F., and S. Normark. 1986. Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene. Eur. J. Biochem. 156:441– 445. 27. Livermore, D. M. 1995. -Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557–584. 28. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607–625. 29. Molbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N. Engl. J. Med. 341:1420–1425. 30. Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. PerezDiaz, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type -lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother. 39:458–461. 31. NCCLS. 1999. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement, vol. 19, no. 1. NCCLS, Wayne, Pa. 32. Pfaller, M. A., R. J. Hollis, and H. S. Sader. 1994. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis, p. 10.5c.1–10.5c.12. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1 (Suppl.). American Society for Microbiology, Washington, D.C. 33. Ramos, J. M., J. M. Ales, M. Cuenca-Estrella, R. Fernandez-Roblas, and F. Soriano. 1996. Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980–1994. Eur. J. Clin. Microbiol. Infect. Dis. 15:85–88. 34. Recchia, G. D., and R. M. Hall. 1995. Gene cassettes: a new class of mobile element. Microbiology 141:3015–3027. 35. Rice, L. B., and R. A. Bonomo. 1996. Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents, p. 453–501. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, Md. 36. Rondon, M. R., S. J. Raffel, R. M. Goodman, and J. Handelsman. 1999. Toward functional genomics in bacteria: analysis of gene expression in Escherichia coli from a bacterial artificial chromosome library of Bacillus cereus. Proc. Natl. Acad. Sci. USA 96:6451–6455. 37. Sandvang, D., F. M. Aarestrup, and L. B. Jensen. 1998. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104. FEMS Microbiol. Lett. 160:37–41. 38. Seyfarth, A. M., H. C. Wegener, and N. Frimodt-Moller. 1997. Antimicrobial resistance in Salmonella enterica subsp. enterica serovar typhimurium from humans and production animals. J. Antimicrob. Chemother. 40:67–75. 39. Tajima, M., Y. Takenouchi, S. Sugawara, M. Inoue, and S. Mitsuhashi. 1980. Purification and properties of chromosomally mediated -lactamase from Citrobacter freundii GN7391. J. Gen. Microbiol. 121:449–456. 40. Thal, L. A., J. W. Chow, J. E. Patterson, M. B. Peri, S. Donabedian, D. B. Clewell, and M. J. Zervos. 1993. Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance. Antimicrob. Agents Chemother. 37:134–137. 41. Threlfall, E. J., J. A. Frost, and B. Rowe. 1999. Fluoroquinolone resistance in salmonellas and campylobacters from humans. Br. Med. J. 318:943–944. (Letter.) 42. Threlfall, E. J., B. Rowe, and L. R. Ward. 1993. A comparison of multiple drug resistance in salmonellas from humans and food animals in England and Wales, 1981 and 1990. Epidemiol. Infect. 111:189–197.
VOL. 44, 2000
ANIMAL AND HUMAN DRUG-RESISTANT SALMONELLA ISOLATES
43. Tosini, F., P. Visca, I. Luzzi, A. M. Dionisi, C. Pezzella, A. Petrucca, and A. Carattoli. 1998. Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 42:3053–3058. 44. Verdet, C., G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterisation of CMY-4, an AmpC-type plasmid-mediated -lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235–240. 45. Wu, S. W., K. Dornbusch, G. Kronvall, and M. Norgren. 1999. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid en-
2783
coding a CMY-type -lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC -lactamase. Antimicrob. Agents Chemother. 43:1350–1357. 46. Yang, Y. J., C. C. Liu, S. M. Wang, J. J. Wu, A. H. Huang, and C. P. Cheng. 1998. High rates of antimicrobial resistance among clinical isolates of nontyphoidal Salmonella in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 17:880– 883. 47. Yildirmak, T., A. Yazgan, and G. Ozcengiz. 1998. Multiple drug resistance patterns and plasmid profiles of non-typhi salmonellae in Turkey. Epidemiol. Infect. 121:303–307.
